Red Maple LifeSciences

EnzyLock Platform

EnzyLock is Red Maple's enzyme-responsive wound dressing platform. It is being developed in stages, from a bacteria-responsive indicator to a postoperative dressing with localized antiseptic and antibiotic response, all engineered to fit into existing surgical dressing workflows.

Cover. Protect. Detect. Respond.

  • Cover

    Provides the same physical wound coverage as a standard postoperative dressing.

  • Protect

    Shields the surgical site from external contamination, just like a conventional dressing.

  • Detect

    Contains a bacteria-responsive material that reacts to enzymes released by colonizing bacteria.

  • Respond

    Releases its therapeutic payload locally, only where bacterial enzyme activity is present.

Diagram of EnzyLock's mechanism across the postoperative timeline, from surgery through localized response and improved healing

A Staged Product Platform

Red Maple is developing EnzyLock as three related products built on the same bacteria-responsive platform, moving from an indicator integrated into partner dressings to an in-house dressing with localized therapeutic response.

  • EnzyLock Signum

    A bacteria-responsive color-change indicator designed for integration into partners' existing wound dressing lines, giving a visible signal when bacterial enzyme activity is present at the wound site.

    Partnership Pathway

  • EnzyLock Capsa

    Red Maple's core postoperative dressing. Combines the bacteria-responsive indicator with a localized antiseptic payload that releases only when triggered by bacterial enzyme activity, without changing how the dressing is applied or monitored.

    In-House Development

  • EnzyLock Capsa+

    Extends the Capsa platform with a bacteria-triggered antibiotic payload, expanding the platform to a broader range of wound indications beyond its initial surgical focus.

    In-House Development

How Capsa Works

Precision antimicrobial delivery

Bacteria-Triggered, Localized Therapy

EnzyLock Capsa releases an encapsulated antiseptic payload locally and only when bacteria are present, replacing the standard workflow of waiting for visible infection and treating after it has already progressed.

How Signum Works

Bacteria-Responsive Indication

The dressing contains a bacteria-responsive component that produces a visible color change on-demand, giving clinicians earlier indication of infection without disrupting monitoring routines.

Real-time detection

Platform Advantages

  • No Added Steps

    Drops into existing dressing-change and monitoring routines without new equipment or extra clinical steps.

  • Single Application

    Designed to function from a single application, without requiring reapplication for continued action.

  • Localized Action

    Payload release stays local to the wound site rather than circulating systemically.

  • Broad Compatibility

    Validated across a broad spectrum of bacteria in preclinical studies, without inducing antimicrobial resistance.